Previous Article | Next Article ![]()
Journal of Bacteriology, May 2008, p. 3489-3493, Vol. 190, No. 10
0021-9193/08/$08.00+0 doi:10.1128/JB.00146-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Biology, Washington University, Campus Box 1137, 1 Brookings Drive, St. Louis, Missouri 63130
Received 28 January 2008/ Accepted 1 March 2008
|
|
|---|
|
|
|---|
- and
-proteobacteria (4, 7, 18, 19). The system I pathway of Escherichia coli is composed of eight integral membrane proteins encoded by the ccmABCDEFGH operon. The functions of some of these proteins have been established. CcmE takes heme from CcmC and acts as a periplasmic heme chaperone (9, 22, 23), and CcmC-bound holo-CcmE can function as a heme reservoir (10). Because heme is bound with high affinity to CcmC (9), an ATP-dependent CcmABC release complex (stoichiometry, A2B1C1) is required to release heme (as holo-CcmE). Holo-CcmE is putatively the substrate for the cytochrome c synthetase (CcmF/H) for subsequent heme ligation to apocytochrome c (2, 9). Using recombinant systems I (E. coli) and II (Helicobacter hepaticus CcsBA) in an E. coli strain with the ccm operon deleted (
ccm) and endogenous heme synthesis deleted (
hemA), we have shown that system I has at least a fivefold-higher affinity for heme than system II (21). This suggests that the heme reservoir holo-CcmE and the CcmA2B1C1 release complex allow system I to use heme at endogenous levels lower than the levels used by system II, thus potentially giving an organism using the system I pathway a distinct physiological advantage over an organism using the system II pathway (21). The function of the short CcmD protein has been a question of considerable interest (1, 13, 20). While CcmD shows little conservation of the primary sequence (Fig. 1), the predicted domain structure consists of a negatively charged N-terminal domain (NTD), a hydrophobic region, and a positively charged C-terminal domain (CTD). In Rhodobacter capsulatus a functional CcmD (HelD)-LacZ fusion coimmunoprecipitated with CcmA, suggesting that it is part of a CcmABC complex and that the CTD is in the cytoplasm (13). In E. coli, CcmD has been shown by coimmunoprecipitation to interact with CcmC and to a lesser extent with CcmE (1). Ahuja and Thony-Meyer concluded that CcmD is an "assembly factor of membrane proteins" involved in "increased incorporation (of CcmE) into the membrane" (1). Recently, we have shown (9) that CcmC, but not CcmD, is necessary for interaction with CcmE (see below). In the present report we characterize the E. coli CcmA2B1C1 release complex and define an essential function for CcmD in the system I pathway. We show that CcmD is not required for the transfer of heme to CcmE but that, as part of the CcmABC release complex, CcmD is required for the release of holo-CcmE from this complex. We also reevaluate the membrane topology of the CcmD protein in E. coli and provide evidence that supports the topology proposed for R. capsulatus CcmD (13), with the NTD oriented in the periplasm and the CTD oriented in the cytoplasm.
![]() View larger version (52K): [in a new window] |
FIG. 1. Alignment of the E. coli CcmD protein with representative bacterial CcmD sequences. The amino acid sequences of CcmD proteins of E. coli K-12 strain MG1655 (accession no. POABM5) (Ec), Nitrospira multiformis ATCC 2516 (YP_411906) (Nm), Nitrosomonas eutropha C71 (YP_747848) (Ne), Polynucleobacter sp. strain QLW-PIDMWA-1 (Psp.), Ralstonia metallidurans CH34 (YP_584534) (Rm), Shigella boydii Sb227 (YP_408515) (Sb), Salmonella enterica subsp. enterica serovar Typhi CT1 (NP_456796) (Set), Erwinia carotovora subsp. atroseptica SCRI1043 (YP_049982) (Ec), Vibrio vulnificus YJ016 (NP_935245) (Vv), Vibrio parahaemolyticus RIMD 2210633 (NP_798599) (Vp), Pasteurella multocida subsp. multocida PM70 (NP_244945) (Pm), Haemophilus influenzae Rd KW20 (NP_439249) (Hi), Psychromonas ingrahamii 37 (ZP_01349302) (Pi), Shewanella putrefaciens CN-32 (ZP_00815699) (Sp), Shewanella oneidensis MR-1 (NP_715900) (So), Rhodobacter sphaeroides 2.4.1 (YP_351852) (Rs), Roseovarius sp. strain 214 (ZP_01034520) (Rsp.), and R. capsulatus SB1003 (P29963) (Rc) were aligned with ClustalW (25). Amino acid similarities are indicated as follows: asterisk and gray shading, identical residues in all sequences; colons, conserved substitution; and period, semiconserved substitution. The predicted domain structure of side chains, the net charges ([R + K] – [D + E]) of the NTD and CTD, and the location of the GXY motif are also indicated.
|
|
|
|---|
ccm) has a deletion of all eight ccm genes (ccmABCDEFGH) and has been previously described (10). All E. coli strains were grown aerobically (with shaking at 300 rpm) at 37°C in Luria-Bertani media (Difco). Antibiotics were obtained from Sigma-Aldrich (St. Louis, MO) and were used at the following concentrations: carbenicillin, 100 µg ml–1; and chloramphenicol, 20.4 µg ml–1. Isopropyl-β-D-thiogalactopyranoside (IPTG) (Sigma-Aldrich) and arabinose (Sigma-Aldrich) were used at final concentrations of 1 mM and 0.2% (wt/vol), respectively.
Construction of plasmids.
E. coli strain TB1 was used as the initial host for all cloning experiments. All oligonucleotide sequences are given in Table 1. A C terminally FLAG-tagged (DYKDDDDK; Sigma-Aldrich) version of CcmD was generated by PCR using pRGK333 (pGEXsystemI) as a template and the oligonucleotide primers ccmDrFLAG and ccmDf-EcoRI. The amplified product was digested with EcoRI and SalI and ligated into pRGK359 (pGEXCcmABC:6XHis [9]) to generate pRGK369 (pGEXCcmABC:6XHisCcmDFLAG). This pGEX4T-1 (GE Healthcare, Piscataway, NJ)-based IPTG-inducible plasmid encodes a glutathione S-transferase (GST) fusion to the N terminus of CcmA, a six-His tag on the C terminus of CcmC, and a FLAG tag on the C terminus of CcmD. A pGEXsystemI plasmid without ccmD and ccmE was engineered in a two-step process. First, ccmABC were amplified from pRGK333 (10) using oligonucleotide primers ccmNterm (10) and
ccmD-left (9), and the PCR product was digested with BglII/EcoRI and ligated into BamHI/EcoRI-digested pGEX4T-1. Second, ccmFGH were amplified from pRGK333 (10) using oligonucleotide primers delccmErt (9) and ccmCterm (10). The PCR product was digested with NdeI/EcoRI and ligated into the intermediate plasmid mentioned above digested with NdeI/EcoRI, resulting in pRGK370 (pGEXsystemI-
ccmDE). To construct a pBAD-derived plasmid expressing CcmE, the ccmE gene was amplified from pRGK333 (10) using oligonucleotide primers ccmEf-NcoI and ccmE*-right (9), digested with NcoI/KpnI, and ligated into NcoI/KpnI-digested pRGK330 (10). In the resulting plasmid, pRGK371 (pBADCcmE:6XHis), the CcmE gene is overexpressed from the araB promoter and is arabinose inducible (not shown). A pBADc4-derived plasmid that contains a gene encoding an N-terminally six-His-tagged CcmD was engineered in a two-step process. First, the CcmD gene was amplified from pRGK333 (10) with oligonucleotide primers ccmDf-NdeI and ccmDr-NdeI, and the PCR product was digested with NdeI and ligated into NdeI-digested pET15b (Novagen-EMD Biosciences, Gibbstown, NJ). Second, this intermediate plasmid was digested with XbaI/XhoI, and the 0.3-kb band containing the His6:CcmD gene was gel purified and ligated into XbaI/SalI-digested pRGK332 (10), yielding pRGK372 (pBADc4-6XHis:CcmD). This plasmid contains a transcriptional fusion of the pET15b-derived E. coli His6:CcmD gene positioned after the Bordetella pertussis cytochrome c4 gene, which is under the control of the araB promoter. A control plasmid containing a gene encoding a protein lacking the N-terminal six-His tag on CcmD was also engineered in a two-step process. First, ccmD was amplified with oligonucleotide primers ccmDf-NcoI and ccmDr-NdeI, and the PCR product was digested with NcoI/NdeI and ligated into NcoI/NdeI-digested pET15b. This intermediate plasmid was digested with XbaI/XhoI, and the 0.25-kb fragment containing the CcmD gene was ligated into XbaI/SalI-digested pRGK332 (10), yielding pRGK373 (pBADc4-CcmD). pRGK373 contains a transcriptional fusion of the pET15b-derived wild-type E. coli CcmD gene after the B. pertussis cytochrome c4 gene, which is under the control of the araB promoter.
|
View this table: [in a new window] |
TABLE 1. Oligonucleotides
|
Protein purification. To purify CcmC:His6, solubilized extracts were passed over a column containing His Bind (Novagen-EMD Biosciences) nickel affinity resin and washed according to the manufacturer's suggestions. FLAG-tagged CcmD was purified from solubilized membrane extracts using FLAG antibody resin (Sigma-Aldrich) according to the manufacturer's specifications. GST: CcmA was purified from solubilized extracts as previously described (9).
Other methods. Protein concentrations were obtained using the bicinchoninic acid assay (Pierce) with bovine serum albumin as a standard. For heme staining and Western blotting, proteins were first separated by 12.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) or, for extracts containing CcmD:FLAG, by using 12.5% Next Gel (Amresco, Solon, OH) and transferred onto Hybond-C nitrocellulose membranes (Hybond; GE Healthcare, Piscataway, NJ). Chemiluminescence from heme or Western blots was detected using the SuperSignal Femto chemiluminescent substrate (Pierce) with a LAS1000plus luminescent image analyzer charge-coupled device camera system (Fujifilm, Valhalla, NY). Heme staining was quantified using a LOLITA II (low light test array; Raytest USA, Wilmington, NC) for standardization of light intensity detection.
|
|
|---|
![]() View larger version (70K): [in a new window] |
FIG. 2. Protein-protein interactions with CcmC:His6 determined by analysis of proteins brought down with a nickel column. E. coli RK103 cultures containing pRGK369 (pGEXCcmABC:6XHisD:FLAG) were grown, membrane proteins were isolated, and nickel affinity chromatography was performed as described in the text. Purified proteins were separated by SDS-PAGE and probed with (A) six-His antisera ( 6xHis), (B) GST antisera ( GST), or (C) FLAG antisera ( FLAG). The positions of standard proteins with the indicated molecular masses (103) are shown on the left, and the positions of CcmC:His6, GST:CcmA, and CcmD:FLAG are indicated by arrows.
|
In order to test whether CcmD affects heme transfer to CcmE, system I plasmids without ccmD and ccmE or without only ccmE were used in conjunction with a plasmid expressing CcmE:His6. To establish that CcmD is required for cytochrome c maturation in this system, we coexpressed the B. pertussis cytochrome c4 and ccmE genes on another plasmid, pRGK349 (10). Only constructs containing ccmD (and other ccm genes) synthesized cytochrome c4 (not shown). When no system I is present with pRGK371 (pBADCcmE:6XHis), no holo-CcmE is detected (Fig. 3, lane 3), consistent with a requirement for CcmC for heme transfer to CcmE and with the hypothesis that there are no background levels of holo-CcmE, as reported previously (9, 20, 22). Holo-CcmE is present in the strain without only CcmD (Fig. 3, lane 2). The same levels of total CcmE (apo-CcmE and holo-CcmE) were detected using antisera to CcmE whether CcmD was present or not (Fig. 3, lanes 4 and 5). Although more holo-CcmE (approximately three times more) is present when CcmD is part of the CcmABCD complex than when CcmD is absent (Fig. 3, compare lanes 1 and 2), we conclude that CcmD is not essential for heme transfer to CcmE or for the stability or membrane insertion of CcmE. Below we address why less holo-CcmE is observed in the CcmD mutant.
![]() View larger version (20K): [in a new window] |
FIG. 3. Heme is transferred to CcmE with or without CcmD. E. coli RK103 harboring pRGK345 and pRGK371 (lanes 1 and 4), pRGK370 and pRGK371 (lanes 2 and 5), or pRGK371 (lane 3) was grown and induced as described in the text. Ten micrograms of crude n-dodecyl-β-D-maltoside-solubilized membrane proteins was separated by SDS-PAGE, the presence of holo-CcmE was detected by heme staining, and total CcmE was detected with CcmE antibodies. A typical gel with heme staining (lanes 1 to 3) and a CcmE Western blot (lanes 4 and 5) are shown, and the percentages of holo-CcmE, corrected for the amount of total CcmE present in each lane, are indicated at the bottom. Abbreviations: ccm, E. coli RK103; SysI E, pRGK345; SysI DE, pRGK370; CcmE:6XHis, pRGK371.
|
![]() View larger version (28K): [in a new window] |
FIG. 4. Holo-CcmE* is not released into the periplasm without CcmD. Periplasmic protein fractions were prepared from E. coli RK103 coexpressing pRGK345 and pRGK362 (lane 1) or pRGK370 and pRGK362 (lane 2). Twenty micrograms of periplasmic proteins was separated by SDS-PAGE and transferred to nitrocellulose. (Top panel) Heme staining showing the levels of holo-CcmE*. (Bottom panel) Immunoblot with CcmE antisera. Abbreviations: ccm, E. coli RK103; SysI E, pRGK345; SysI DE, pRGK370; CcmE*:6XHis, pRGK362; CcmE, CcmE antisera.
|
Ahuja and Thony-Meyer (1) did not show whether the addition of a six-His tag and other residues (see below) to the NTD might interfere with the optimal function of CcmD. Evaluation of the CcmD NTD and CTD (Fig. 1) for the inside-out rule (6, 15, 17) suggested that the addition of the six-His tag plus the adjoining 14 amino acids of vector-derived sequence (MGSSHHHHHHSSGLVPRGSH) added by Ahuja and Thony-Meyer (1) would affect the inside-out rule via the charge of the NTD (from –1 to at least +2). This could possibly lead to a change in the topology of most CcmD molecules in the membrane. To determine whether the addition of the pET15b-derived six-His tag to the N terminus of CcmD affects its activity, we constructed two "activity" reporter plasmids. We engineered the B. pertussis cytochrome c4 reporter plasmid (pRGK332) to include either His6:CcmD or untagged wild-type CcmD. The plasmids were constructed so that the ribosome-binding site (RBS) sequence and spacing to the ATG start codon, the six-His tag, and other vector-derived sequence were identical to those used by Ahuja and Thony-Meyer (1). A plasmid with the identical RBS but lacking the six-His tag and additional pET15b-derived amino acid sequence was constructed and served as the wild-type CcmD control plasmid for cytochrome c4 expression studies. Note also that the DNA upstream of the RBS and the spacing and sequence to the ATG of the six-His tag and wild-type CcmD are identical. Cytochrome c4 levels were used to estimate the "activity" of His6:CcmD and CcmD. The maximum level (defined as 100%) of cytochrome c4 from pRGK373 (wild-type CcmD) was detected with 0.02% arabinose (Fig. 5, lane 3). The maximum level of cytochrome c4 from pRGK372 (pBADc4-6XHis:CcmD) was also detected with 0.02% arabinose (Fig. 5, lane 10), but it was only 13% of the wild-type level. In general, quantification of "activity" with different arabinose concentrations indicates that the six-His tag on the NTD reduces function by approximately 90%. These results suggest that the addition of the six-His tag plus the 14 amino acids of pET15b sequence to the NTD of CcmD (MGSSHHHHHHSSGLVPRGSH) leads to highly reduced function of His6:CcmD when data are directly compared (Fig. 5, compare lanes 2 to 7 to lanes 9 to 14) to data for wild-type CcmD with the natural NTD sequence (MTPAFASWNE) (Fig. 1). Although other explanations are possible, the six-His tag could change the topology of the CcmD and hence reduce the function. The fact that some function remains could be because a small percentage of molecules have the NTD outside or because only proteolysed (i.e., proteolysis of the six-His tag) CcmD can assume the proper conformation. Our results suggest that the protease sensitivity data (1) and hence conclusions concerning CcmD NTD topology are based on nonfunctional CcmD molecules. Other lines of evidence also suggest that the topology of E. coli CcmD is the same as that suggested for R. capsulatus CcmD (12, 13). As mentioned above, the positive-inside/negative-outside rule (6, 15, 17) for membrane protein topology predicts that the CcmD NTD (charge, at least –1) is on the outside of the cytoplasmic membrane in all CcmD homologs (Fig. 1). The CTD is highly positively charged, consistent with the LacZ fusion results that place it in the cytoplasm. Because CcmD is required for the periplasmic release of holo-CcmE*, it is possible that a domain of CcmD in the periplasm is involved in protein-protein (or protein-heme) interactions with the CcmABCD release complex and/or holo-CcmE. After aligning the N termini of many CcmD proteins, we noted a completely conserved GXY motif (Fig. 1) that may be involved in such release interactions.
![]() View larger version (25K): [in a new window] |
FIG. 5. Heme staining of holocytochrome c4:His6 induced with increasing concentrations of arabinose shows that an N-terminal six-His tag on CcmD reduces its function. E. coli RK103 coexpressing pRGK353 and either pRGK373 (lanes 1 to 7) or pRGK372 (lanes 8 to 14) was grown and treated as described in the text. A typical blot to determine the levels of holocytochrome c4 (indicated at the bottom) compared to 100% (lane 3) is shown. The concentrations of arabinose are indicated above the lanes. The molecular masses of the standards (lane Std) are 29.2 kDa (top band) and 20.2 kDa (bottom band). Abbreviations: CCM, E. coli RK103; SysI D, pRGK353; pBADc4-CcmD, pRGK373; pBADc4-6XHis:CcmD, pRGK372; c4, B. pertussis cytochrome c4.
|
Published ahead of print on 7 March 2008. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»